Binding of imipramine to plasma proteins: Effect of hyperlipoproteinemia
- 1 March 1979
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 25 (3) , 316-321
- https://doi.org/10.1002/cpt1979253316
Abstract
The binding of imipramine to plasma proteins was studied by equilibrium gel filtration. Imipramine was highly bound to lipoproteins as well as to other plasma proteins. The binding to the lipoproteins was higher in hyperlipoproteinemic patients than in normal subjects and correlated well with both plasma cholesterol and triglyceride levels. The overall percent binding of imipramine was also higher in hyperlipoproteinemic patients than in normal subjects. It is concluded that the varying degree of binding of imipramine to plasma proteins as a result of varying lipoprotein concentrations, as well as the special nature of the binding to lipoproteins, may be of kinetic and possibly clinical significance in hyperlipoproteinemic individuals.This publication has 6 references indexed in Scilit:
- Binding of insecticides to human serum proteinsToxicology and Applied Pharmacology, 1978
- Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemiasClinical Pharmacology & Therapeutics, 1978
- Plasma protein binding of basic drugsClinical Pharmacology & Therapeutics, 1977
- PLASMA-PROTEIN BINDING OF BASIC DRUGS .1. SELECTIVE DISPLACEMENT FROM ALPHA1-ACID GLYCOPROTEIN BY TRIS(2-BUTOXYETHYL) PHOSPHATE1977
- Binding of Drugs to Serum AlbuminNew England Journal of Medicine, 1976
- Gel filtration behaviour of human serum lipoproteinsClinica Chimica Acta; International Journal of Clinical Chemistry, 1966